PSORIASIS

 

PSORIASIS

 

DEFINITION:

A chronic cutaneous disorder characterized by papules which coalsce to form plaques covered by a thick silvery or yellow-white scale.

EPIDEMIOLOGY:

  • incidence: 1-2% of the population
  • age of onset:
    • 35% by age 20 years
    • 10% by age 10 years
    • 2% by age 2 years
  • risk factors:
    • F > M (2:1)
    • whites > blacks, Asians, Indians

PATHOGENESIS:

1. Background

  • accelerated epidermal turnover results in the accumulation of thick scales over the affected areas of skin
  • most patients have mild disease limited to sites of frequent trauma and irritation (knee, elbows, scalp, groin, sacrum)

2. Etiology

  • while the etiology is unknown, the expression of the disease seems to be dependent upon a susceptible host being exposed to specific triggers:
  • 1. Genetic Predisposition (Susceptible Host)
    • 58% of affected children have a first degree relative with psoriasis
    • risk of psoriasis with one affected parent: 25%
    • risk of psoriasis with two affected parents: 60%
    • concordance rate is greater in monozygotic (70%) vs dizygotic (15-20%) twins
    • HLA B-17, Cw6, DR6
  • 2. Specific Triggers
  • 1. Infections
    • Group A beta-hemolytic Streptococcus (pharyngeal, rectal), measles, tinea pedis
  • 2. Environment
    • cold weather
  • 3. Trauma
    • Koebner's Phenomenon - appearance of psoriasis at sites of trauma (abrasions, bites, burns, excor-iations, radiation, skin tests, sunburn, tattoos, vaccinations, venipuncture, surgery)

3. Types of Psoriasis

1. Major

  • Plaque-Type
  • Guttate
  • Inverse

2. Minor

  • Generalized Pustular (von Zumbusch type, Annular)
  • Localized Pustular (Palmoplantar, Acrodermatits continua)
  • Erythrodermic

CLINICAL FEATURES:

1. Cutaneous Manifestations

1. Plaque-Type Psoriasis

  • round, red, dry, circumscribed plaques covered with a silvery white, thick, adherent scale
  • plaques range in size from 1-10 cm in diameter
  • predilection for extensor surfaces of large joints, sacrum, and scalp
  • Ausptiz sign
    • pinpoint bleeding upon intentional removal of lesion
  • Woronoff's ring
    • blanched area around the perimeter of a healing lesion
  • Geographic tongue
    • psoriasis manifested on the tongue

2. Guttate Psoriasis

  • multiple discrete tear-shaped lesions covered with a silvery scale (paint spray)
  • lesions range from 0.5-1.5 cm in diameter
  • predilection for the trunk, proximal extremities, and face
  • usually triggered by a streptococcal infection, viral infections, sunburn, and systemic corticosteroid withdrawal
  • onset characterized by an explosive eruption of erythematous macules which persist for 6-8 weeks

3. Inverse Psoriasis

  • skin in affected areas become red and macerated but not scaly
  • predilection for intertriginous (axillae, gluteal cleft, perineum) and diaper areas

2. Other Manifestations

1. Nail

  • may be the sole manifestation of psoriasis
  • pitting, leukonychia (white spots), longitudinal ridges and grooves, tranverse depressions, reddish-brown discolouration of the nailbed (oil spots),
  • nail psoriasis
    • crumbling of the nail bed
    • hyperkeratosis (subungual debris)
    • onycholysis (detachment of the nail)

2. Musculoskeletal

  • 1. Seronegative Arthritis
    • found in <10% of patients
    • distal joints more likely to be affected
    • can occur before, during, or after development of psoriasis
  • INVESTIGATIONS:

    1. Skin Biopsy

    • thickened stratum corneum with perakeratosis (nuclei retained in the stratum corneum)
    • hyperplastic epidermis containing microabscesses
    • increased vascularization and inflammation of the dermis

    MANAGEMENT:

    1. Supportive

    • avoid specific triggers (cold weather, infections, trauma)
    • aggressive treatment of streptococcal infections
      • penicillin, erythromycin
      • five days of rifampin to decrease the rate of chronic streptococcal carriage
    • avoid dry skin with proper skin care
      • daily baths with minimal use of mild soaps and cleaners
      • thick lubricant or emollient over damp skin
      • increase exposure to sun (but avoid sunburns)
    • psychotherapy or group therapy for severe cases

    2. Medications

    1. Keratolytics

    • salicylic or lactic acid preparations (2-10%)
    • should be incorporated into a bland, ointment-type vehicle (white petrolatum or Aquaphor)

    2. Tar Preparations

    • mainstay of psoriasis therapy
    • act by reducing epidermal cell DNA synthesis and mitotic activity of the hyperplastic epidermis
    • topical oils, emollients, and gels; shampoos
    • crude coal tar (1-3%), liquor carbonis detergens (5-10%)

    3. Topical Steroids

    • low -> high potency (Class I agents)
    • use 1-2.5% hydrocortisone to facial & intertriginous areas
    • use 0.025-0.1% corticosteroid preparations to other areas

    4. Others

  • 1. Anthralin
  • 2. Calcipotriol
    • a topical vitamin D analogue
  • 3. Ultraviolet Radiation Therapy

    • UVB
    • UVA +/- psoralens (PUVA)

    4. Scalp Psoriasis

    • tar shampoos, keratolytics, moderate-potency topical steroid solutions
    • may apply topical steroid solutions to small affected areas od or bid

    5. Prognosis

    • psoriasis is a chronic condition with flares and remissions which may worsen with age

     

     

     

    Pediatric Database - PSORIASIS

    Pediatric Organization - Pedbase [at] Gmail.com